Neisseria Meningitidis Completed Phase 3 Trials for Meningococcal polysaccharide vaccine group A (DB13889)

IndicationStatusPhase
DBCOND0030896 (Neisseria Meningitidis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01839175Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster VaccinationPrevention